| Renal benefits of SGLT 2 inhibitors and GLP-1 receptor agonists: evidence supporting a paradigm shift in the medical management of type 2 diabetes V Ninčević, T Omanović Kolarić, H Roguljić, T Kizivat, M Smolić, ... International journal of molecular sciences 20 (23), 5831, 2019 | 85 | 2019 |
| Targeting the Wnt signaling pathway in liver fibrosis for drug options: an update K Duspara, K Bojanic, JI Pejic, L Kuna, TO Kolaric, V Nincevic, R Smolic, ... Journal of clinical and translational hepatology 9 (6), 960, 2021 | 47 | 2021 |
| Drug-induced fatty liver disease: Pathogenesis and treatment TO Kolaric, V Nincevic, L Kuna, K Duspara, K Bojanic, S Vukadin, ... Journal of clinical and translational hepatology 9 (5), 731, 2021 | 38 | 2021 |
| The role of GLP1-RAs in direct modulation of lipid metabolism in hepatic tissue as determined using in vitro models of NAFLD A Petrovic, D Igrec, K Rozac, K Bojanic, L Kuna, TO Kolaric, V Mihaljevic, ... Current issues in molecular biology 45 (6), 4544-4556, 2023 | 24 | 2023 |
| Risk factors contributing to the occurrence and recurrence of hepatocellular carcinoma in hepatitis C virus patients treated with direct-acting antivirals S Kishta, A Tabll, T Omanovic Kolaric, R Smolic, M Smolic Biomedicines 8 (6), 175, 2020 | 22 | 2020 |
| Antimicrobial resistance and antimicrobial stewardship: Before, during and after the COVID-19 pandemic O Khaznadar, F Khaznadar, A Petrovic, L Kuna, A Loncar, ... Microbiology Research 14 (2), 727-740, 2023 | 13 | 2023 |
| Molecular mechanisms linking empagliflozin to renal protection in the LLC-PK1 model of diabetic nephropathy V Mihaljević, M Zjalić, T Kizivat, T Omanović Kolarić, M Smolić, E Rođak, ... Biomedicines 10 (11), 2983, 2022 | 9 | 2022 |
| Pretreatment of garlic oil extracts hampers epithelial damage in cell culture model of peptic ulcer disease L Kuna, M Zjalic, T Kizivat, H Roguljic, V Nincevic, T Omanovic Kolaric, ... Medicina 58 (1), 91, 2022 | 9 | 2022 |
| Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug … T Omanovic Kolaric, T Kizivat, V Mihaljevic, M Zjalic, I Bilic-Curcic, L Kuna, ... Current issues in molecular biology 44 (8), 3465-3480, 2022 | 8 | 2022 |
| Green Tea Polyphenol (-)-Epicatechin Pretreatment Mitigates Hepatic Steatosis in an In Vitro MASLD Model M Hefer, A Petrovic, LK Roguljic, TO Kolaric, T Kizivat, CH Wu, AA Tabll, ... Current issues in molecular biology 46 (8), 8981, 2024 | 3 | 2024 |
| Preclinical models and promising pharmacotherapeutic strategies in liver fibrosis: an update TO Kolaric, L Kuna, M Covic, H Roguljic, A Matic, R Sikora, M Hefer, ... Current issues in molecular biology 45 (5), 4246-4260, 2023 | 3 | 2023 |
| Primary care provider counseling practices about adverse drug reactions and interactions in Croatia N Raguz Lucic, J Jakab, M Smolic, AM Milas, T Omanovic Kolaric, ... Journal of clinical medicine 7 (9), 231, 2018 | 3 | 2018 |
| Pharmacogenomics: sex differences and application in pediatrics I Bozic, T Omanovic, L Kuna, T Kizivat, R Smolic, A Vcev, M Smolic Southeastern European Medical Journal: SEEMEDJ 1 (1), 108-120, 2017 | 2 | 2017 |
| Pharmacogenomics: recent progress, sex gender differences, translation into clinical practice, application in pediatrics and future perspectives M Smolic, I Bozic, T Omanovic, L Kuna, T Kizivat, R Smolic, A Vcev Southeastern European Medical Journal 1 (1), 108-120, 2017 | 2 | 2017 |
| Semaglutide significantly increases cell viability and ameliorates lipid accumulation in an in vitro model of MASLD A Petrovic, M Hefer, T Omanovic Kolaric, L Kuna Roguljic, T Kizivat, ... | | 2024 |
| SEMAGLUTIDE DIRECTLY AFFECTS VIABILITY OF HEPATOCYTES, STEATOSIS EXTENT AND KEY PROTEINS INVOLVED IN LIPID METABOLISM IN AN IN VITRO MODEL OF MASLD A Petrović, M Hefer, L Kuna Roguljic, T Omanovic Kolaric, T Kizivat, ... 13th ISABS Conference on Applied Genetics and Mayo Clinic Lectures in …, 2024 | | 2024 |
| Pretreatment with (-)-epicatechin attenuates the development of NAFLD in vitro M Hefer, A Petrovic, T Omanovic Kolaric, L Kuna Roguljic, T Kizivat, N Srb, ... | | 2024 |
| MODULATION OF SREBF1 AND MTTP LEVELS BY (-)-EPICATECHIN PRETREATMENT IN AN IN VITRO MODEL OF MASLD M Hefer, A Petrovic, L Kuna Roguljic, T Omanovic Kolaric, N Raguz Lucic, ... 13th ISABS Conference on Applied Genetics and Mayo Clinic Lectures in …, 2024 | | 2024 |
| IN A CELL CULTURE MODEL OF TAMOXIFEN-INDUCED STEATOSIS ANTISTEATOTIC EFFECT OF LIRAGLUTIDE IS MEDIATED THROUGH ACSL1 And SREBP-1c SIGNALING PATHWAY M Smolic, TO Kolaric, T Kizivat, V Mihaljevic, L Kuna, M Zjalic, IB Curcic, ... BRITISH JOURNAL OF PHARMACOLOGY 180, 1378-1379, 2023 | | 2023 |
| Home-Based Exercise During the Coronavirus Pandemic–A Useful, yet Challenging Treatment Strategy for Improvement of Mental Health, Glycemic Control and COVID-19 Outcomes in … M Cigrovski Berković, M Ivandić, A Mrzljak, V Cigrovski, ... Southeastern European Medical Journal: SEEMEDJ 7 (1), 28-35, 2023 | | 2023 |
